List of FDA-approved peptides PDF The landscape of therapeutic peptides is rapidly expanding, with the U.S. Food and Drug Administration (FDA) approving an increasing number of these complex molecules for various medical applications. The FDA-approved peptide drugs represent a significant advancement in pharmaceutical development, offering targeted treatments for conditions ranging from diabetes and cancer to rare genetic disorders.THPdb2: compilation of FDA approved therapeutic ... Understanding the scope and impact of these approved peptides is crucial for patients, healthcare providers, and researchers alike.
The approval of peptide drugs by the FDA has seen a notable surge in recent years. Reports indicate a substantial increase in the number of therapeutic peptides gaining FDA sanction, with figures suggesting over 100 such drugs have been approved.ANDAs for Certain Highly Purified Synthetic Peptide Drug ... This trend highlights the growing recognition of peptides' therapeutic potential and their ability to address unmet medical needs2025年2月5日—FDA-approved peptide drugs, including GLP-1 therapies for diabetes, peptide therapeutics for cancer, and innovations in peptide drug .... For instance, in a single year, several novel drugs, including peptides and oligonucleotides, received FDA approval, underscoring the dynamic nature of this field.2017 FDA Peptide Harvest The development of peptide-based drugs is a testament to scientific innovation, with ongoing research focusing on enhancing their delivery, efficacy, and stability.Peptide therapeutics: current status and future opportunity ...
Peptide therapeutics are making significant inroads across a diverse range of medical conditions. Some of the most prominent areas include:
* Diabetes and Metabolic Disorders: GLP-1 receptor agonists, a class of peptide drugs, have revolutionized the management of type 2 diabetes and obesity. Medications like liraglutide and semaglutide, which mimic the action of the natural incretin hormone, have demonstrated remarkable efficacy in improving glycemic control and promoting weight loss. Insulin itself, a protein (and thus a larger peptide relative), has long been a cornerstone therapy for diabetesThis review reports on the unexpected and considers able number ofpeptidesthat are currently available asdrugsand the chemical strategies that were used to ....
* Oncology: Peptide-based drugs are being developed and approved for various cancers作者：HU Jeong·2024—1.Trofinetide (DaybueTM) · 2. Rezafungin (RezzayoTM) · 3. Flotufolastat F 18 (PoslumaTM) · 4. Nirmatrelvir/Ritonavir (PaxlovidTM) · 5.. These can include peptide-drug conjugates or peptides that target specific cancer cell receptors2024 FDA Approvals: 50 New Drugs. For example, certain cyclic peptides have shown promise in treating hematological malignancies like multiple myeloma.
* Rare Diseases and Genetic Disorders: The FDA has approved peptide drugs for specific rare conditions. Trofinetide, for instance, is approved for the treatment of Rett syndrome, a rare neurological disorder.
* Infectious Diseases: Peptide-based antifungals, such as Rezafungin, have received approval for treating serious fungal infections like candidemia.
* Cardiovascular Conditions: While not always explicitly termed "peptide drugs" in common parlance, some cardiovascular medications have peptide origins or mechanisms of action. Captopril, an ACE inhibitor, is one example of a drug derived from peptide research.
* Hormone Replacement and Other Endocrine Disorders: Peptides that mimic natural hormones are used to treat various endocrine imbalances. Tesamorelin, for example, is approved for HIV-related lipodystrophy.Peptide Drugs: Discovery and Development Explained
The diversity of approved peptide drugs, including linear, cyclic, and lipopeptide structures, reflects the versatility of peptide chemistry in drug design.
The FDA's approval process for peptide drugs involves rigorous evaluation of safety and efficacy.作者：W Xiao·2025·被引用次数：186—Over the past two decades, the number of peptide drugs approved by the FDA ... Among thesix peptide drugs approved in 2023, three are cyclic ... Recent trends indicate a growing interest in specific types of peptides:
* Cyclic Peptides: These molecules, characterized by a ring-like structure, often exhibit enhanced stability and potency compared to their linear counterparts. Several cyclic peptides have been approved in recent years for indications like candidemia and multiple myeloma.作者：S Jain·2024·被引用次数：35—The THPdb2 database is an updated version of THPdb andprovides the latest comprehensive information on FDA-approved therapeutic peptidesand proteins. The ...
* Macrocyclic Peptides: Similar to cyclic peptides, macrocyclic structures are gaining traction, with a number of these therapeutics approved over the past two decades....FDA-approved therapeutic peptidesare administered via 3 different routes: intravenous, oral, and subcutaneous. As indicated in Table 1, intravenous ...
* Peptide-Drug Conjugates (PDCs): This emerging class combines the targeting specificity of peptides with the potent cytotoxic effects of small molecule drugs, offering a promising approach for cancer therapyCurrent Status of Peptide Medications and the Position ....
The development of peptide-based drug delivery systems is also a critical area of research, aiming to overcome challenges such as poor oral bioavailability and short half-lives, thereby improving patient compliance and treatment outcomes.
The FDA provides guidance for the development and submission of applications for synthetic peptide drug products, ensuring a standardized approach to quality and safety. Databases like THPdb and THPdb2 serve as valuable resources, compiling comprehensive information on FDA-approved therapeutic peptides and proteins, aiding researchers and industry professionals.FDA's stamp of approval: Unveiling peptide breakthroughs ...
The pipeline for peptide therapeutics remains robust, with ongoing clinical trials exploring their potential for a wide array of diseases.作者：HU Jeong·2024—1.Trofinetide (DaybueTM) · 2. Rezafungin (RezzayoTM) · 3. Flotufolastat F 18 (PoslumaTM) · 4. Nirmatrelvir/Ritonavir (PaxlovidTM) · 5. As scientific understanding and technological capabilities advance, the number of FDA-approved peptides is expected to continue its upward trajectory, offering new hope and innovative treatment options for patients worldwide. The "peptide craze" in drug development is backed by solid scientific progress and a growing number of successful therapeutic applications.
Join the newsletter to receive news, updates, new products and freebies in your inbox.